| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |